BÜHLMANN Announces Home Testing Device For IBD Patients

The BÜHLMANN Press Release on the Calprotectin home test for the Fight IBD day at ECCO 2014 Copenhagen.

Link to Press Release

For further reading on the topic you find links here:

– Fecal Calprotectin correlates more closely with the simple endoscopic score for Crohns Disease than CRP, Blood Leukocytes, and the CDAI. Schöpfer et al. 

– Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease. D’Haens et al.

– Faecal marker of gastorintestinal inflammation. Sherwood et al.

– A new rapid quantitative test for fecal calprotectin predicts endoscopic activity in Ulcerative Colitis. Lobaton et al.

– A new rapid test for fecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn’s Disease. Lobaton et al. 

– Role of endoscopy, cross-sectional imaging and biomarkers in Crohn’s disease monitoring. Benitez et al.

– Consecutive fecal calprotectin measurements to predict relapse in patients with Ulcerative Colitis receiving Infliximab maintenance therapy. De Vos et al.